These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12898010)

  • 21. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
    Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.
    Thankamony A; Tossavainen PH; Sleigh A; Acerini C; Elleri D; Dalton RN; Jackson NC; Umpleby AM; Williams RM; Dunger DB
    J Clin Endocrinol Metab; 2014 Feb; 99(2):639-47. PubMed ID: 24423298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsatile intravenous insulin replacement in streptozotocin diabetic rats is more efficient than continuous delivery: effects on glycaemic control, insulin-mediated glucose metabolism and lipolysis.
    Koopmans SJ; Sips HC; Krans HM; Radder JK
    Diabetologia; 1996 Apr; 39(4):391-400. PubMed ID: 8777988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
    Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
    Basu R; Basu A; Nielsen M; Shah P; Rizza RA
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults.
    Krusenstjerna-Hafstrøm T; Clasen BF; Møller N; Jessen N; Pedersen SB; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2548-57. PubMed ID: 21613350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
    Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
    J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes.
    Edge JA; Matthews DR; Dunger DB
    Diabetes Res; 1990 Nov; 15(3):109-12. PubMed ID: 2132202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
    Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.
    Lindberg-Larsen R; Møller N; Schmitz O; Nielsen S; Andersen M; Orskov H; Jørgensen JO
    J Clin Endocrinol Metab; 2007 May; 92(5):1724-8. PubMed ID: 17341562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose and fatty acid metabolism in type 2 diabetes mellitus: an assessment using low-dose insulin infusion and the hyperinsulinaemic euglycaemic clamp.
    Webber J; Whitelaw D; Smith JM; Nattrass M
    Diabetes Obes Metab; 1999 May; 1(3):173-8. PubMed ID: 11220296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML; Widmer B; Dunger DB; Dalton RN
    Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.
    Rave K; Heise T; Weyer C; Sawicki P; Heinemann L
    Exp Clin Endocrinol Diabetes; 1999; 107(5):313-7. PubMed ID: 10482044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.
    Acerini CL; Cheetham TD; Edge JA; Dunger DB
    Diabetologia; 2000 Jan; 43(1):61-8. PubMed ID: 10663217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
    Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
    de Zegher F; Ong K; van Helvoirt M; Mohn A; Woods K; Dunger D
    J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel use of the hyperinsulinemic-euglycemic clamp technique to estimate insulin sensitivity of systemic lipolysis.
    Stumvoll M; Wahl HG; Löblein K; Becker R; Volk A; Renn W; Jacob S; Häring H
    Horm Metab Res; 2001 Feb; 33(2):89-95. PubMed ID: 11294499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.